Pricing Log in Create free account

Dermata Therapeutics, Inc. (DRMA) vs Enlivex Ltd. (ENLV)

Dermata Therapeutics, Inc. and Enlivex Ltd. are both Biotechnology companies. Dermata Therapeutics, Inc. and Enlivex Ltd. are of similar size ($4.5M and $4.5M). Dermata Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Enlivex Ltd. trades at 0.0×. Across the 11 metrics below, Enlivex Ltd. leads on 6 and Dermata Therapeutics, Inc. on 5.

Valuation

Metric DRMA ENLV Biotechnology median
P/E n/m 0.00 8.50
P/S n/m n/m 9.71
P/B 0.99 0.00 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.03 240.66 0.64
EV/Sales n/m n/m 9.21
Earnings yield (510.47%) 248,526.43% (33.15%)
Free cash flow yield (232.27%) (301.79%) (25.50%)

Profitability

Metric DRMA ENLV Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (183.89%) 159.77% (56.36%)
Return on assets (139.93%) 127.16% (48.04%)
Return on invested capital 0.00% (5.85%) 0.00%

Growth

Metric DRMA ENLV Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 89.84% 3,590.26% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DRMA ENLV Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.81 119.39 4.72
Net debt to EBITDA 0.97 118.29 0.96

Dividend

Metric DRMA ENLV Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DRMA ENLV Biotechnology median
Market cap 4.51m 4.46m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack